KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Esperion Therapeutics (ESPR) Non-cash Items (2016 - 2020)

Esperion Therapeutics filings provide 4 years of Non-cash Items readings, the most recent being $72.4 million for Q2 2020.

  • On a quarterly basis, Non-cash Items rose 2237.34% to $72.4 million in Q2 2020 year-over-year; TTM through Jun 2020 was $72.4 million, a 2237.34% increase, with the full-year FY2019 number at $109.1 million, up 3704.52% from a year prior.
  • Non-cash Items hit $72.4 million in Q2 2020 for Esperion Therapeutics, up from $3.2 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $173.1 million in Q1 2018 to a low of $2.6 million in Q2 2018.
  • Median Non-cash Items over the past 4 years was $72.4 million (2020), compared with a mean of $67.2 million.
  • Biggest five-year swings in Non-cash Items: crashed 98.27% in 2019 and later surged 2237.34% in 2020.
  • Esperion Therapeutics' Non-cash Items stood at $165.4 million in 2017, then crashed by 49.53% to $83.5 million in 2018, then surged by 30.65% to $109.1 million in 2019, then tumbled by 33.61% to $72.4 million in 2020.
  • The last three reported values for Non-cash Items were $72.4 million (Q2 2020), $3.2 million (Q1 2020), and $109.1 million (Q4 2019) per Business Quant data.